The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.

https://www.foxnews.com/health/wild-west-peptide-craze-surges-beyond-glp-1s-fda-faces-pressure-ease-access